Mvasi

Active Ingredient(s): Bevacizumab-awwb
FDA Approved: * September 14, 2017
Pharm Company: * AMGEN INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mvasi Overview

Bevacizumab, sold under the trade name Avastin, is medication used to treat a number of types of cancers and a specific eye disease.[3] For cancer it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma.[3] For age-related macular degeneration it is given by injection into the eye.[3] Common side effects when use for cancer include nose bleeds, headache, high blood pressure, and rash.[3] Other severe side effects include gastroi...

Read more Mvasi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bevacizumab

Recent Mvasi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bevacizumab-awwb
  • Injection: 100mg/4ml (25mg/ml), 25mg/ml, 400mg/16ml (25mg/ml)
  • Vial: 100mg, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Bevacizumab-awwb or a similar ingredient: (2 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 November 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.